Back to search

Article

A MyCAF-Based Signature for Prognosis, Immune Landscape, and Therapeutic Response in Pancreatic Cancer

2026-03-18

Abstract excerpt

<title>Abstract</title> <p>Pancreatic ductal adenocarcinoma (PDAC) remains a highly aggressive cancer with a poor prognosis, driven in part by a complex tumor microenvironment where myofibroblastic cancer-associated fibroblasts (myCAFs) are key players. This study aimed to develop and validate a robust myCAF-related gene signature for prognostic stratification and therapeutic guidance in PAAD. Clinical and transc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
30458e89-24a5-5bb7-8376-684c97611a71
DOI
10.21203/rs.3.rs-8878509/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A MyCAF-Based Signature for Prognosis, Immune Landscape, and Therapeutic Response in Pancreatic CancerDOI 10.21203/rs.3.rs-8878509/v1
Select a neighboring publication to make it the new centre.